** Shares of Monash IVF Group MVF.AX rise 4.7% to A$1.22
** Stock hits highest level since mid-January
** The fertility services provider posts 1H25 underlying NPAT of A$15.8 million, up 5.5% from previous year
** Co expects to record underlying group NPAT between A$30 million and A$31 million in FY25 compared to A$29.9 million in FY24
** Co posts 1H25 revenue growth of 11.6% to A$10.3 million
** About 810,200 shares change hands, 1.3 times the 30-day average volume of shares
** Stock down 8.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。